After being diagnosed with multiple sclerosis (MS) in 2021, living with severe symptoms, and becoming one of the most famous celebrities with the disorder, Christina Applegate learned some shocking news: She doesn't actually have MS.
In an October 20, two-part episode of her podcast "MeSsy" with Jamie Lynn Sigler (another actor diagnosed with MS), Applegate shared that she took over half a year off from recording the podcast to process the news of her MS misdiagnosis.
According to Applegate, her doctor framed the revelation as a positive update. "She came into my room and said, 'Congratulations, you don't have MS,'" Applegate said in the podcast.
But to Applegate, no longer having an explanation for the pain, balance issues, tremors, incontinence, and fatigue she'd been living with for years felt more like being "back at square one."
"You don't get misdiagnosed and then all of a sudden, I'm better," she said. "If anything, I've gotten worse, in some ways."
Applegate's story is far from a medical anomaly. MS researchers estimate that about 15% of worldwide MS patients are actually misdiagnosed, based on a 2024 meta-analysis of multiple studies.
Two researchers shared why MS is so challenging to diagnose — and why more people might end up with Applegate's experience in the future.
The race to diagnose a hard-to-diagnose disorder
There is no single blood test that can diagnose MS.
Instead, doctors often piece together an MS diagnosis using a neurological exam (testing balance and reflexes), MRI scans, a lumbar puncture (or spinal tap), and possible blood tests to rule out other conditions such as Lyme disease.
Sometimes, doctors overrely on a single diagnostic, such as an MRI finding, without performing enough other tests, Dr. Andrew J. Solomon, a professor of neurological sciences at the University of Vermont who co-authored the meta-analysis, told Business Insider.
In 2019, Solomon co-authored an MS misdiagnosis study that found that patients who were initially diagnosed with MS were later told they actually had other conditions, such as migraine, radiologically isolated syndrome, spondylopathy, and neuropathy, which can share overlapping symptoms with MS and similar brain scan results.
In the podcast, Applegate revealed that she had a nerve test to rule out peripheral neuropathy, as well as MRIs and a lumbar puncture. While her spinal fluid test showed a low level of immune proteins that can support an MS diagnosis, she had nearly 40 brain lesions and worsening symptoms, leading doctors to diagnose her with MS.
Solomon said MS should be diagnosed by "confirming each element of our diagnostic criteria and ruling out other things," rather than assuming it must be MS if the MRIs and symptoms fit.
The problem is, both physicians and patients are eager to diagnose MS as early as possible, he said. Correctly spotting MS early can lead to better treatment results and a higher likelihood of disability prevention, according to research.
Plus, for patients dealing with a plethora of debilitating symptoms, "a period of diagnostic uncertainty is uncomfortable," he said, even though the best course of action is to wait and perform more tests.
A new testing protocol revealed Applegate's misdiagnosis
In the podcast, Applegate shared that her brain lesions were missing "strings" associated with MS.
It's a finding associated with a new, more accurate diagnostic tool for MS, Dr. Marwa Kaisey, an associate professor of neurology at Cedars-Sinai, who co-authored the 2019 study with Solomon, explained on the podcast.
The central vein sign (CVS), is an MRI biomarker that can help differentiate MS brain lesions from ones associated with other disorders. It refers to a small vein that appears as a dot or thin line through the center of a brain lesion.
CVS was only recently adapted as part of the recommended MS diagnostic criteria, in 2025 — four years after Applegate was first diagnosed with MS.
Solomon hopes more doctors will include CVS in their diagnostic protocols, especially for existing MS patients or those who switch providers without being evaluated by their current doctors. "If something doesn't fit, there's an opportunity there to reevaluate if the diagnosis is right," he said.
Many misdiagnosed MS patients feel exactly like Applegate does
When it comes to learning about an MS misdiagnosis, Solomon said experiences like Applegate's aren't that uncommon.
"I've heard many stories where some doctor was very enthusiastic about telling a patient they actually didn't have MS," he said. "But many of these patients are suffering, and they still have symptoms. So it's not always necessarily a happy thing."
For Applegate, her initial MS diagnosis provided clarity and direction. "That was my answer to everything that was going on," Applegate said. Some might relate to Applegate's "square one" feeling, particularly if their doctor was an MS specialist and won't see them anymore, Solomon said. Without a formal diagnosis, they might also worry about insurance coverage for treatments that have provided some relief.
There is also the emotional part of having an MS diagnosis. "I leaned into other friends, I leaned into the community," Applegate said. "I had a reason as to why my day sucked every day, and now I don't have a reason."
Knowing she doesn't have MS also made her feel like she "let everybody down" after becoming one of the "poster children for MS," she said. It made her wonder if she was somehow imagining symptoms or at fault for her pain.
Given how common MS misdiagnosis is, Solomon believes it's a good thing that Applegate is sharing her story.
"It's kind of wonderful that Ms. Applegate is public with this because if the number is really 15%, you can do the math," he said. "There are a lot of people out there who might ask their doctors about the accuracy of their diagnosis and find out that, in fact, they had something else."
This article is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your qualified physician or healthcare provider.
Read next
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Julia is a senior health reporter at Business Insider. Julia covers a wide range of topics, including the rise of colon cancer cases among young people, the unique challenges modern parents face, and the growing trend of Gen Zers abstaining from social media. She also writes about fitness, nutrition, longevity, and the routines of highly successful people for Business Insider’s Power Hours series. She’s published interviews with Arnold Schwarzenegger, Serena Williams, Esther Perel, Bill Nye, Naomi Watts, and James Van Der Beek.Julia's work has appeared on the BBC, CBS, Bloomberg Radio, Morning Brew, Fast Company, and the Daily Flash. She has also moderated panel discussions at Nasdaq and Duke University, and appeared on the podcasts Open to Debate, Airtalk, The Evan Bray Show, and The Last Show with David Cooper. Prior to this role, Julia was an education and personal development editor on the Business Insider Reviews team and a sex and relationships editor at Cosmopolitan and BuzzFeed, respectively. You can say hi to Julia at [email protected] and check out more of her work on her website.

1 hour ago
23